2,4-thiazolidinedione has been researched along with Idiopathic Parkinson Disease in 3 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, HL | 1 |
| Lin, HC | 1 |
| Tseng, YF | 1 |
| Chao, JC | 1 |
| Hsu, CY | 1 |
| Connolly, JG | 1 |
| Bykov, K | 1 |
| Gagne, JJ | 1 |
| Carta, AR | 1 |
| Pisanu, A | 1 |
1 review available for 2,4-thiazolidinedione and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Modulating microglia activity with PPAR-γ agonists: a promising therapy for Parkinson's disease?
Topics: Animals; Antiparkinson Agents; Encephalitis; Humans; Microglia; Parkinson Disease; Pioglitazone; PPA | 2013 |
2 other studies available for 2,4-thiazolidinedione and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Association of thiazolidinedione with a lower risk of Parkinson's disease in a population with newly-diagnosed diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Diabetes Mellitus; Dose-Response Relationship, | 2018 |
Thiazolidinediones and Parkinson Disease: A Cohort Study.
Topics: Aged; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Parkinso | 2015 |